Published: Guidance, quality standards and advice
Showing 31 to 32 of 32
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab | TA357 | ||
| Pembrolizumab for advanced melanoma not previously treated with ipilimumab | TA366 |